Ardelyx (ARDX) Change in Acquisitions & Divestments (2017 - 2026)
Ardelyx (ARDX) posted Change in Acquisitions & Divestments of $37.9 million for Q1 2026, down 31.0% on a QoQ basis from $55.0 million in Q4 2025, and up 9.28% year-over-year from $34.7 million in Q1 2025.
Ardelyx (ARDX) Change in Acquisitions & Divestments (2017 - 2026) Analysis & Trends
Ardelyx's Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at $37.9 million for Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 9.28% year-over-year to $37.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $214.7 million (up 18.62% YoY) and the FY2025 annual result came in at $211.5 million, up 18.89% from the prior year.
- Change in Acquisitions & Divestments was $37.9 million for Q1 2026 at Ardelyx, down from $55.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $63.3 million in Q3 2025 and bottomed at $8.0 million in Q4 2022.
- A 5-year average of $34.0 million and a median of $34.7 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments slumped 63.64% — and 2023, when it jumped 500.71%.
- Ardelyx's Change in Acquisitions & Divestments stood at $8.0 million in 2022, then soared by 500.71% to $48.1 million in 2023, then grew by 19.65% to $57.5 million in 2024, then decreased by 4.35% to $55.0 million in 2025, then plunged by 31.0% to $37.9 million in 2026.
- Business Quant data shows ARDX's Change in Acquisitions & Divestments at $37.9 million in Q1 2026, $55.0 million in Q4 2025, and $63.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.27 Bn | 1.03 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.95 Mn |
| Mar 31, 2026 | 37.95 Mn |
| Dec 31, 2025 | 55.00 Mn |
| Dec 31, 2025 | 55.00 Mn |
| Sep 30, 2025 | 63.35 Mn |
| Sep 30, 2025 | 63.35 Mn |
| Jun 30, 2025 | 58.38 Mn |
| Jun 30, 2025 | 58.38 Mn |
| Mar 31, 2025 | 34.73 Mn |
| Mar 31, 2025 | 34.73 Mn |
| Dec 31, 2024 | 57.50 Mn |
| Dec 31, 2024 | 57.50 Mn |
| Sep 30, 2024 | 42.24 Mn |
| Sep 30, 2024 | 42.24 Mn |
| Jun 30, 2024 | 46.51 Mn |
| Jun 30, 2024 | 46.51 Mn |
| Mar 31, 2024 | 31.60 Mn |
| Mar 31, 2024 | 31.60 Mn |
| Dec 31, 2023 | 48.06 Mn |
| Dec 31, 2023 | 48.06 Mn |